Business Economy


Wockhardt announces exit from generics drugs Business in US

Mumbai, July 12 (UNI) Pharma company Wockhardt stated in a regulatory filing that it will exit from the US generic drugs market.
The move has come after years of sustained losses in the segment, with the company's generics business posting a loss of approximately $8 million in FY25.
Wockhardt stated in a regulatory filing on Friday that it has initiated voluntary liquidation proceedings for its two US subsidiaries, namely Morton Grove Pharmaceuticals Inc and Wockhardt USA LLC, under Chapter 7 of the US Bankruptcy Code. Both the companies incorporated in Delaware, United States, are wholly owned by Wockhardt Bio AG.
Wockhardt’s statement emphasised that the exit from the US generics sector will enhance its ability
to deliver sustainable profitability through innovation and scientific leadership. The company reiterated its commitment to pharmaceutical operations in India, the UK, Ireland, and other international markets, where its businesses continue to perform profitably.
The decision is part of Wockhardt’s broader plan to streamline operations and concentrate on its high-value, innovation-driven product lines. By exiting the US generics market, the company aims
to redirect capital and executive focus toward two key growth areas of novel antibiotics and its biologicals portfolio, particularly in insulin-based therapies.
Earlier, Wockhardt’s founder chairman Habil Khorakiwala had hinted about the move, saying that the company would move away from commoditised generics in the US and concentrate on launching innovative drugs developed in Europe at FDA-approved facilities.
This approach aligns with Wockhardt’s long-term goal of transforming into a research-led pharmaceutical firm with a global footprint, he had stated.
UNI XC BM
More News

Finance Minister hails Modi's strong leadership and policy initiatives on becoming India's longest-serving Prime Minister

10 Jun 2026 | 12:27 PM

New Delhi, Jun 10 (UNI) Finance Minister Nirmala Sitharaman Wednesday praised PM's strong leadership and key policy initiatives on his record as India's longest-serving PM.

see more..

Tarzan Nature Retreat Launches Licensing Model to Organise India's Offbeat Hospitality Sector

09 Jun 2026 | 11:36 PM

Hyderabad, June 9 (UNI) Tarzan Nature Retreat, the nature-hospitality platform of EBG Group, on Tuesday announced the launch of its Tarzan Licensing and Property Upgrade Model aimed at transforming unorganised offbeat accommodation properties into branded nature-hospitality destinations.

see more..

Apollo Tyres emerges fastest climber in Global Brand Strength Rankings for 2026

09 Jun 2026 | 9:23 PM

Kochi, June 9 (UNI) Leading tyre manufacturer Apollo Tyres Ltd has emerged as the fastest climber in the 2026 Global Tyre Brand Strength rankings released by brand valuation consultancy Brand Finance, registering a significant improvement in its global brand standing driven by strategic marketing initiatives, sports sponsorships and product innovation.

see more..

DPIIT leads Industry outreach in UP to accelerate reforms, exports and investment growth

09 Jun 2026 | 7:20 PM

Lucknow, Jun 9 (UNI) The Department for Promotion of Industry and Internal Trade (DPIIT), Government of India, in collaboration with Invest UP, on Tuesday organized an awareness workshop on key government schemes, programmes and policy initiatives, bringing together leading industry associations and stakeholders to enhance outreach, strengthen industry engagement, and promote wider participation in India's industrial growth agenda.

see more..

Stock markets snap two-day losing streak, Sensex Gains Nearly 400 pts

09 Jun 2026 | 7:09 PM

New Delhi, Jun 9 (UNI) Indian stock markets snapped a two-day losing streak and ended higher amid easing geopolitical tensions and moderation in crude oil prices.

see more..